Felix Hoffmann in 1890 with the pharmaceutical state exam. In 1891 he graduated magna cum laude from the University of Munich. Two years later he earned his doctorate, also magna cum laude, after completing his thesis entitled "On certain derivatives of dihydroanthracene". In 1894, he joined Bayer as a research chemist. On 10 August 1897 Hoffmann synthesized acetylsalicylic acid (ASA) while working at Bayer under Arthur Eichengrün. By combining salicylic acid with acetic acid, he succeeded in creating ASA in a chemically pure and stable form. The pharmacologist responsible for verifying these results was skeptical at first, yet once several large-scale studies
4-Aminosalicylic acid tuberculosis. Like many commercially significant compounds, PAS has many names including "para"-aminosalicylic acid, "p"-aminosalicylic acid, 4-ASA, and simply P. 4-Aminosalicylic acid 4-Aminosalicylic acid, also known as "para"-aminosalicylic acid (PAS) is an antibiotic primarily used to treat tuberculosis. Specifically it is used to treat active drug resistant tuberculosis together with other antituberculosis medications. It has also been used as a second line agent to sulfasalazine in people with inflammatory bowel disease such as ulcerative colitis and Crohn's disease. It is typically taken by mouth. Common side effects include nausea, abdominal pain, and diarrhea. Other side effects may include liver inflammation and